Comera Life (CMRA) Stock Price, News & Analysis
Company Description
Comera Life (OTC Link: CMRA) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $6.1K.
For FY2022, Comera Life reported revenue of $633K with net income of -$18.0M and diluted earnings per share of -$1.76. The company operates at a net profit margin of -2843.8%.
This page collects what Stock Titan holds for CMRA, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Comera Life (CMRA) stock last closed at $0.0000. At a market capitalization of $6.1K, CMRA is classified as a micro-cap stock with approximately 30.7M shares outstanding.
Latest News
Comera Life has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 3 with negative movement. Key topics include management, earnings, private placement. View all CMRA news →
SEC Filings
Financial Highlights
Comera Life generated $633K in revenue in FY2022, retaining a 66.8% gross margin, operating income reached -$12.0M (-1890.7% operating margin), and net income was -$18.0M, reflecting a -2843.8% net profit margin. Diluted earnings per share stood at -$1.76. The company generated -$9.8M in operating cash flow. With a current ratio of 0.61, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Comera Life (CMRA) currently stands at 4.3 thousand shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment. With 1000.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Comera Life (CMRA) currently stands at 1000.0 days, up 1448.5% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
CMRA Company Profile & Sector Positioning
Comera Life (CMRA) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing CMRA often look at related companies in the same sector, including Novaccess Global Inc (XSNX), Statera Biopharma Inc (STAB), BETTER THERAPEUTICS INC (BTTX), Evelo Biosciences (EVLO), and Renovacare (RCAR). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CMRA's relative position within its industry.